Robert Kramer - May 8, 2021 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
May 8, 2021
Transactions value $
-$5,792
Form type
4
Date filed
5/11/2021, 04:25 PM
Next filing
Feb 24, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$5.79K -94 -0.06% $61.62* 163K May 8, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated.